Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
4.74
Dollar change
-0.03
Percentage change
-0.63
%
IndexRUT P/E- EPS (ttm)-2.18 Insider Own50.07% Shs Outstand42.06M Perf Week-1.66%
Market Cap321.23M Forward P/E- EPS next Y-1.62 Insider Trans0.00% Shs Float33.84M Perf Month13.67%
Income-121.83M PEG- EPS next Q-0.48 Inst Own25.21% Short Float1.90% Perf Quarter17.62%
Sales0.00M P/S- EPS this Y1.15% Inst Trans-2.03% Short Ratio8.74 Perf Half Y54.40%
Book/sh4.32 P/B1.10 EPS next Y19.05% ROA-48.91% Short Interest0.64M Perf Year-20.34%
Cash/sh3.44 P/C1.38 EPS next 5Y30.10% ROE-56.33% 52W Range1.66 - 8.56 Perf YTD11.01%
Dividend Est.- P/FCF- EPS past 5Y-43.14% ROI-48.25% 52W High-44.66% Beta1.50
Dividend TTM- Quick Ratio10.79 Sales past 5Y0.00% Gross Margin- 52W Low185.54% ATR (14)0.36
Dividend Ex-Date- Current Ratio10.79 EPS Y/Y TTM10.59% Oper. Margin0.00% RSI (14)59.30 Volatility7.09% 8.27%
Employees128 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price4.75
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-0.72% Payout- Rel Volume0.44 Prev Close4.77
Sales Surprise- EPS Surprise8.16% Sales Q/Q- EarningsFeb 15 AMC Avg Volume73.61K Price4.74
SMA205.20% SMA5022.14% SMA20029.68% Trades Volume32,074 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Mar-13-24Initiated JMP Securities Mkt Outperform $7
Feb-20-24Downgrade H.C. Wainwright Buy → Neutral $5
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $10 → $4
Nov-21-22Downgrade BofA Securities Neutral → Underperform $8 → $6
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $19 → $11
Jul-29-22Initiated Jefferies Buy $9
Mar-15-22Downgrade BofA Securities Buy → Neutral $50 → $10
Feb-28-22Downgrade Barclays Overweight → Equal Weight $20 → $12
Oct-08-21Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-27-21Upgrade BofA Securities Neutral → Buy $60
Mar-05-24 04:45PM
Feb-29-24 04:05PM
Feb-15-24 04:05PM
Dec-11-23 09:34AM
Nov-03-23 08:42AM
05:55AM Loading…
05:55AM
Nov-01-23 04:10PM
04:05PM
Oct-14-23 12:30PM
Oct-04-23 12:00PM
Aug-29-23 08:30AM
Aug-17-23 09:56AM
Aug-03-23 08:00AM
Jul-10-23 08:13AM
Jun-02-23 11:36AM
08:30AM Loading…
May-31-23 08:30AM
May-28-23 08:11AM
May-18-23 07:00AM
May-17-23 04:08PM
May-08-23 08:30AM
Apr-27-23 08:30AM
Apr-11-23 08:30AM
Apr-07-23 09:34AM
Mar-18-23 06:48PM
Mar-16-23 12:06PM
Mar-15-23 08:30AM
08:00AM
Mar-01-23 08:30AM
Feb-09-23 09:05AM
Jan-30-23 09:38AM
07:05AM Loading…
Dec-24-22 07:05AM
Nov-25-22 08:06AM
Nov-14-22 08:00AM
Oct-18-22 08:00AM
Sep-06-22 08:00AM
Aug-23-22 06:39AM
Aug-10-22 09:25AM
Aug-09-22 08:00AM
Jul-05-22 09:22PM
Jun-22-22 09:55AM
May-25-22 06:35AM
May-10-22 08:00AM
Mar-16-22 07:30AM
06:39AM
Mar-11-22 08:00AM
Mar-09-22 08:05AM
08:00AM
Feb-11-22 07:00AM
Jan-04-22 07:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Dec-16-21 09:41AM
Dec-15-21 07:15PM
Dec-08-21 08:47AM
Nov-23-21 07:00AM
Nov-19-21 11:51AM
Nov-12-21 08:00AM
Nov-08-21 09:00AM
Oct-18-21 08:24PM
Oct-07-21 03:12PM
12:55PM
12:28PM
11:15AM
10:16AM
09:00AM
Sep-25-21 10:06AM
Sep-09-21 07:07PM
Sep-02-21 07:00AM
Aug-12-21 07:30AM
Aug-11-21 06:49AM
Jul-19-21 07:00AM
May-13-21 07:15AM
May-11-21 07:30AM
May-05-21 07:00AM
Apr-20-21 07:42AM
Mar-16-21 08:00AM
Mar-03-21 07:00AM
Jan-11-21 06:20PM
Jan-07-21 12:12AM
Jan-04-21 04:16PM
Dec-25-20 04:01AM
Dec-15-20 11:42PM
Nov-10-20 07:30AM
Oct-02-20 08:00PM
Oct-01-20 11:57AM
Sep-30-20 07:00AM
Sep-29-20 04:05PM
Sep-25-20 02:31PM
08:47AM
Sep-24-20 08:50PM
10:52AM
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vaddi KrishnaCEOMay 25 '23Buy5.319004,7791,067,275May 26 04:20 PM
Lim Bryant DavidChief Legal Officer, Corp Sec.May 24 '23Buy5.392,40012,9362,400May 25 04:07 PM
Vaddi KrishnaCEOMay 24 '23Buy5.011,0005,0111,066,375May 26 04:20 PM
Vaddi KrishnaCEOMay 23 '23Buy5.6311,85666,7491,065,375May 25 04:03 PM
Chardonnet LaurentChief Financial OfficerMay 23 '23Buy5.505,00027,50042,165May 25 04:05 PM
ORBIMED ADVISORS LLCDirectorMay 22 '23Buy5.75869,5654,999,99910,119,756May 24 05:09 PM
Bonita David PDirectorMay 22 '23Buy5.75869,5654,999,99910,119,756May 24 05:07 PM
Huang JanePresident, CMOApr 06 '23Sale6.1213,28081,27424,220Apr 06 06:19 PM